AIRLINK 195.11 Increased By ▲ 0.28 (0.14%)
BOP 9.80 Decreased By ▼ -0.01 (-0.1%)
CNERGY 7.32 Decreased By ▼ -0.04 (-0.54%)
FCCL 40.36 Increased By ▲ 1.78 (4.61%)
FFL 16.40 Decreased By ▼ -0.05 (-0.3%)
FLYNG 28.65 Increased By ▲ 1.11 (4.03%)
HUBC 132.53 Increased By ▲ 0.78 (0.59%)
HUMNL 13.95 Increased By ▲ 0.09 (0.65%)
KEL 4.60 Decreased By ▼ -0.06 (-1.29%)
KOSM 6.66 No Change ▼ 0.00 (0%)
MLCF 46.33 Increased By ▲ 0.94 (2.07%)
OGDC 214.98 Increased By ▲ 0.99 (0.46%)
PACE 6.89 Increased By ▲ 0.03 (0.44%)
PAEL 40.51 Increased By ▲ 0.45 (1.12%)
PIAHCLA 16.70 Decreased By ▼ -0.09 (-0.54%)
PIBTL 8.38 Increased By ▲ 0.06 (0.72%)
POWER 9.76 Increased By ▲ 0.33 (3.5%)
PPL 183.75 Increased By ▲ 1.56 (0.86%)
PRL 42.10 Increased By ▲ 0.27 (0.65%)
PTC 24.87 Increased By ▲ 0.31 (1.26%)
SEARL 103.90 Increased By ▲ 1.37 (1.34%)
SILK 1.00 No Change ▼ 0.00 (0%)
SSGC 39.75 Increased By ▲ 0.31 (0.79%)
SYM 17.44 Increased By ▲ 0.11 (0.63%)
TELE 8.76 No Change ▼ 0.00 (0%)
TPLP 12.70 Decreased By ▼ -0.05 (-0.39%)
TRG 65.41 Increased By ▲ 0.01 (0.02%)
WAVESAPP 11.15 Increased By ▲ 0.04 (0.36%)
WTL 1.70 No Change ▼ 0.00 (0%)
YOUW 3.96 Increased By ▲ 0.02 (0.51%)
BR100 12,016 Increased By 41.6 (0.35%)
BR30 36,425 Increased By 278.9 (0.77%)
KSE100 113,646 Increased By 202.7 (0.18%)
KSE30 35,734 Increased By 98.3 (0.28%)
Business & Finance

Brazil health regulator eyes import of AstraZeneca vaccine from India

  • Based on the data presented by Brazilian biomedical center Fiocruz, along with more information to be presented by the Serum Institute of India.
Published January 4, 2021

BRASILIA: Brazilian health regulator Anvisa has received data regarding the AstraZeneca COVID-19 vaccine being produced in India from the vaccine maker's partners in Brazil, the agency said in a statement on Monday.

Based on the data presented by Brazilian biomedical center Fiocruz, along with more information to be presented by the Serum Institute of India, Anvisa said it will evaluate how comparable the vaccine is to the shot produced in the U.K. before it decides on possible approval for emergency use.

Comments

Comments are closed.